3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
9
Lymphoid
5
Plasma cell
2
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
136
Motor Activity
72
Fatigue
10
Neoplasms
9
Obesity
8
Lymphedema
8
Colorectal Neoplasms
7
Weight Loss
6
Cardiotoxicity
6
Prostatic Neoplasms
5
Breast Cancer Lymphedema
5
Ovarian Neoplasms
3
Breast Cancer Female
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Overweight
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lung Neoplasms
2
Insulin Resistance
2
Depression
2
Breast Diseases
2
Breast Cancer Survivors
2
Body Weight Changes
2
Atherosclerosis
2
Arthralgia
2
Ventricular Dysfunction, Left
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
Cyclophosphamide
4
Flow Cytometry
3
Surveys and Questionnaires
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Methylprednisolone
2
Methods
2
Melphalan
2
Immunologic Techniques
2
Filgrastim
2
Data Collection
2
Blood Specimen Collection
2
Azacitidine
2
Alemtuzumab
2
tanespimycin
1
sargramostim
1
ruxolitinib
1
rucaparib
1
ribociclib
1
pembrolizumab
1
motexafin gadolinium
1
liposomal doxorubicin
1
fludarabine phosphate
1
flt3 ligand protein
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
cc-486
1
bosutinib
1
aldesleukin
1
abiraterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
Exercise
×
Breast
×
Clear all
NCT02796365
2018-12-13
HF-PROACTIVE
Henry Ford Health System
Phase NA
Completed
29 enrolled